Suchergebnisse - "SIEVERS QUINLAN"

PubPharm (26)

1

SWI/SNF regulation of germinal center fate and lymphomagenesis

enthalten in: Cancer cell | 2024

von Sievers, Q. | Abdel-Wahab, O.

2

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

enthalten in: Science (New York, N.Y.) | 2024

von Montoya, S. | Bourcier, J. | Noviski, M. | +50

CommentIn: Nat Rev Drug Discov. 2024 Mar;23(3):173. - PMID 38336888

3

UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability

enthalten in: Molecular cell | 2023

von Tsai, J. | Aguirre, J. | Li, Y. | +32

CommentIn: Mol Cell. 2023 Aug 3;83(15):2616-2618. - PMID 37541216

4

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

enthalten in: Nature cancer | 2023

von de Matos Simoes, R. | Shirasaki, R. | Downey-Kopyscinski, S. | +38

5

Methods of characterizing resistance to modulators of Cereblon

enthalten in: Europäisches Patentamt | 2022

von EBERT BENJAMIN LEVINE | SIEVERS QUINLAN

6

METHODS OF CHARACTERIZING RESISTANCE TO MODULATORS OF CEREBLON

enthalten in: Europäisches Patentamt | 2022

von EBERT BENJAMIN LEVINE | SIEVERS QUINLAN

7

Methods of identifying a polypeptide target for degradation by a modulator of CRBN

enthalten in: Europäisches Patentamt | 2021

von MIKKELSEN TARJEI | EBERT BENJAMIN LEVINE | SIEVERS QUINLAN

8

Methods of identifying a polypeptide target for degradation by a modulator of CRBN

enthalten in: Europäisches Patentamt | 2021

von MIKKELSEN TARJEI | EBERT BENJAMIN LEVINE | SIEVERS QUINLAN

9

MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS

enthalten in: Europäisches Patentamt | 2021

von JAN MAX | SIEVERS QUINLAN | EBERT BENJAMIN | +1

10

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

enthalten in: Science translational medicine | 2021

von Jan, M. | Scarfò, I. | Larson, R. | +17

ErratumIn: Sci Transl Med. 2022 Apr 13;14(640):eabq3419. - PMID 35417193